| Line item | 2024-12-31 FY | 2023-12-31 FY | 2022-12-31 FY | 2022-09-30 FY | 2022-06-30 FY | 2021-12-31 FY |
|---|---|---|---|---|---|---|
| Revenue | – | – | – | – | – | – |
| Cost of Revenue | – | – | – | – | – | – |
| Gross Profit | – | – | – | – | – | – |
| Operating Expenses | $1.29B | $567.58M | $354.90M | $133.69M | $72.64M | $21.80M |
| R&D | – | – | – | – | – | – |
| SG&A | $22.23M | $26.51M | $23.96M | – | – | $12.63M |
| Operating Income | -$1.27B | -$559.87M | -$331.48M | -$125.18M | -$67.31M | -$3.79M |
| Interest Expense | $420.03M | $289.17M | $121.01M | $46.18M | $24.35M | $27.05M |
| Tax Expense | $0.00 | $0.00 | $0.00 | – | – | $0.00 |
| Net Income | -$360.50M | -$56.35M | -$7.42M | -$2.07M | -$1.88M | $3.21M |
| EPS (basic) | -359.9500 | -158.0200 | – | – | – | – |
| EPS (diluted) | -359.9500 | -158.0200 | – | – | – | – |
| Shares (diluted) | $1.00M | $356.59K | – | – | – | – |